111 Net Income 2018-2024 | YI
111 net income from 2018 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| 111 Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-9 |
| 2023 | $-55 |
| 2022 | $-60 |
| 2021 | $-105 |
| 2020 | $-70 |
| 2019 | $-72 |
| 2018 | $-55 |
| 2017 | $-38 |
| 111 Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-3 |
| 2024-09-30 | $-2 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-2 |
| 2023-12-31 | $-30 |
| 2023-09-30 | $-13 |
| 2023-06-30 | $-8 |
| 2023-03-31 | $-5 |
| 2022-12-31 | $-15 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-17 |
| 2021-12-31 | $-19 |
| 2021-09-30 | $-39 |
| 2021-06-30 | $-25 |
| 2021-03-31 | $-22 |
| 2020-12-31 | $-23 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-18 |
| 2019-12-31 | $-22 |
| 2019-09-30 | $-17 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-18 |
| 2018-09-30 | $-18 |
| 2018-06-30 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.066B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Tempus AI (TEM) | United States | $11.232B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.424B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |